1. Home
  2. PSQH vs JSPR Comparison

PSQH vs JSPR Comparison

Compare PSQH & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

HOLD

Current Price

$3.39

Market Cap

29.3M

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

SELL

Current Price

$0.53

Market Cap

26.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PSQH
JSPR
Founded
2021
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
26.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
PSQH
JSPR
Price
$3.39
$0.53
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
38.6K
★ 360.5K
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.00
19.22
EPS
N/A
★ N/A
Revenue
★ $5,685,987.00
N/A
Revenue This Year
$81.45
N/A
Revenue Next Year
$35.13
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 1096.61
N/A
52 Week Low
$0.36
$0.32
52 Week High
$6.94
$2.69

Technical Indicators

Market Signals
Indicator
PSQH
JSPR
Relative Strength Index (RSI) 30.66 43.85
Support Level $0.51 $0.42
Resistance Level $5.73 $0.60
Average True Range (ATR) 0.35 0.05
MACD -0.12 -0.00
Stochastic Oscillator 5.61 41.17

Price Performance

Historical Comparison
PSQH
JSPR

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: